Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation by Marino, IR et al.
Treatment of Hepatic Epithelioid Hemangioendothelioma 
With Liver Transplantation 
IGNAZIO R. MARINO, MD, SATORU TODO, MD, ANDREAS G. TZAKIS, MD, GORAN KLiNTMALM, MD, PHD: 
MICHAEL KELLEHER, MD, SHUNZABURO IWATSUKI, MD, THOMAS E. STARZL, MD, PHD, 
AND CARLOS O. ESQUIVEL, MD, PHD 
Ten patients received liver transplants for unresectable epithelioid hemangioendothelioma (EHE). At the 
time of transplantation, four patients had microscopic metastases to the hilar lymph nodes, and one of 
the four also had metastases to a rib. The fifth patient had metastases to the lung, pleura, and diaphragm. 
The remaining five patients were believed to be free of metastatic disease. Two of these five patients died 
of metastatic disease at 3 and 16 months, respectively, after transplantation. Interestingly, all five patients 
with metastatic involvement are currently alive 40.6 ± 22 months (mean ± standard error oCmean (SEMI) 
after transplantation, although one of these patients currently has metastatic disease to the lungs and 
mediastinum. Thus, the projected 5-year actuarial survival rate is 76%, with two patients at risk after 
the third year. In conclusion, liver transplantation is a reasonable procedure Cor bulky, otherwise unre-
sectable, EHE even in the presence oC metastatic disease. 
Cancer 62:2079-2084, 1988. 
E PITHELIOlD HEMANGIOENDOTHELIOMA (EHE) is a 
soft tissue malignant tumor that is characterized by 
its epithelioid appearance and vascular endothelial his-
togenesis. It was specifically identified histologically by 
Weiss and Enzingerl in 1982. In 1975, a similar if not 
identical tumor occurring in the lung was described by 
Dail and Liebow who proposed the term "intravascular 
bronchioalveolar tumor.,,2 In 1984, Ishak et al. reported 
for the first time 32 patients with primary EHE of the 
liver. 3 
The current definition of EHE as a unique form of 
vascular lesion consisting of endothelial cells is based on 
the presence of immunohistochemical staining for Factor 
VIII-related antigen in the tumor. I-S Using this specific 
definition, only a few cases of EHE have been described 
in the literature, particularly as primary hepatic malig-
nancies, although EHE may occur more often than it is 
reported. 1.6-8 
The therapeutic approaches used in the clinical man-
agement of this tumor have been variable because of the 
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limited clinical experience with this malignancy. There 
have been two separate single case reports of patients with 
EHE who have been treated with orthotopic liver trans-
plantation (OLT).9,IO 
Herein we report the results with hepatic transplanta-
tion in ten patients with EHE. In each of these patients, 
the tumor was unresectable using any of several different 
conventional subtotal hepatectomy procedures. 
Patients and Methods 
Patient Profile 
Between March 1963 and October 1987, 1281 patients 
had transplants performed at either the University of Col-
orado or University of Pittsburgh Health Centers or the 
Baylor University Medical Center. In 91 of these patients 
(7.1 %), the indication for OL T was a primary hepatic ma-
lignancy that could not otherwise be resected. The his-
tologic diagnosis in ten of these 91 patients was EHE. 
Only one of these ten patients has been reported cur-
rently.3 Their ages ranged from 24 to 52.5 years (median 
age, 29.5 years). Six often patients were female. 
After OLT, the immunosuppression consisted of aza-
thioprine and prednisone for the first two patients and 
cyclosporine and prednisone for the subsequent eight pa-
tients. 
All ten patients were evaluated initially in different in-
stitutions. They were referred to one of our hospitals for 
liver transplantation because the malignant lesions were 
deemed unresectable except as a total hepatectomy. Before 
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TABLE 1. Clinical Features 
Preoperative 
Patient Total bilimbin SGOT SGPT AP GGT 
no. First symptoms (mgjdl) 
I Abdominal pain, vomiting, jaundice 17.9 
2 Chest and abdominal pain, palpable 
mass 
3 Pyrosis, transient jaundice 
4 15-lb weight loss, pruritus, spider 
angiomas, ascites 
5 Incidental investigation for trauma 
causing back pain, otherwise 
asymptomatic 
6 Right subcostal pain 
7 Abdominal pain, IO-Ib weight loss, 
anorexia 
8 Abdominal pain 
9 Abdominal pain 
SGOT: serum glutamic oxaloacetic transaminase; SGPT: serum glu-
transplantation, the patients were subjected to a thorough 
evaluation to rule out the presence of any metastatic dis-
ease. This included an ultrasonographic examination of 
the abdomen (with particular attention to the presence of 
any vascular lesions), computerized axial tomography of 
the chest, abdomen, and head, a bone scan for the detec-
tion of metastases, complete upper and lower gastroin-
testinal endoscopy, and chest roentgenograms. Occasion-
ally, an arteriogram or laparoscopy also was performed. 
The correct diagnosis of ERE was known preoperatively 
in six patients. In two other patients, the diagnosis was 
not made until the excised liver was examined histolog-
ically and Factor VIII-related antigen was detected im-
munocytochemically as being present within the tumor 
cells. The initial histopathologic diagnosis was erroneous 
in two patients (the first two). A recent review of their 
histologic material showed the correct diagnosis. 
Clinical Features, Operation, and Findings 
Complete clinical data were available in nine of ten 
patients. In one patient, only the operative records and 









(IU/I) (IU/I) (IU/I) (IU/l) 
80 30 425 
20 25 221 ISO 
97 54 810 459 
18 10 273 176 
21 16 80 25 
25 19 100 46 
57 93 388 201 
48 35 352 101 
16 16 119 42 
tamic pyruvic transaminase; AP: alkaline phosphatase; GGT: gamma-
glutamyl transpeptidase. 
sisting of Adriamycin (Adria Laboratories, Columbus, 
OR) (Table 2). The one patient who originally was thought 
to have a fibrolamellar hepatocellular carcinoma received 
intraarterial hepatic chemotherapy and 2400 cGy of ex-
ternal hepatic radiation before OLT. The patient with 
metastasis to the left second rib underwent rib resection 
after radiation therapy to the area. 
The technique for liver replacement was similar to that 
reported elsewhere, except that the recipient hepatectomy 
included the gastrohepatic ligament, the hepatoduodenal 
ligament, and skeletonization of all vascular structures in 
the hepatic hilum. 11 The common bile duct was transected 
distally as it passed behind the duodenum and the biliary 
reconstruction was performed using an end-to-side donor 
choledochus to a recipient Roux-en-Y jejunal limb. In 
one patient, a portion of the diaphragm was excised be-
cause of local tumor invasion. The diaphragmatic defect 
in this case was repaired with Marlex mesh. 
One patient was known to have metastatic disease in-
volving the left second rib before OLT. In addition, four 
other patients were found to have metastases at the time 
of the transplant surgery. One of these had involvement 
of the lung, pleura, and diaphragm. The other three had 
microscopic involvement of their hilar lymph nodes (Ta-
ble 2). 
As shown in Table 1, pain was the most common initial 
symptom of the disease, with a nonspecific intestinal dis-
turbance being the second most common complaint. Two 
patients had jaundice, one with ascites and one with a 
palpable hepatic mass. Another patient experienced ob-
struction oflarge intrahepatic biliary ducts with cholestasis 
and symptoms of veno-occlusive disease. Liver injury 
variables often showed nonspecific abnormalities, and all 
but one patient· had an increased alkaline phosphatase 
and gamma-glutamyl transpeptidase (GGT) level. 
Pathologic Studies 
Although a standard protocol for chemotherapy has 
not been instituted yet, four patients did receive postop-
erative adjuvant chemotherapy after transplantation con-
Six of 10 patients had a preoperative biopsy diagnosis 
of ERE. Tn each of those patients, the original surgical 
pathology was reviewed before OLT. All hepatectomy 
specimens underwent a complete pathologic examination 
according to a standard liver transplant protocol used at 
our institutions. In each case, the tumor was weighed and 
fixed in 10% formalin. The extent of tumor within the 
liver, the surgical margins, and the number oflymph nodes 
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TABLE 2. Gross Pathologic Findings and Clinical Results 
Hepatic 
Patient tumor 
no. Liver weight location Pre-OLT metastases 
4800 Multifocal Abdomen, lungs, pleura and 
diaphragm invasion 
2 1720 Multifocal No 
3 1610 Multifocal No 
4 6670 Multifocal Hylar lymph nodes, 
common bile duct 
5 1450 Multifocal Extrahepatic lymph nodes, 
left lung 
6 1600 Multifocal Hylar lymph nodes 
7 1400 Multifocal Extrahepatic lymph nodes 
8 2240 Multifocal No 
9 1800 Multifocal No 
10 2510 Multifocal No 
OL T: orthotopic liver transplantation. 
included were documented and appropriate sections were 
removed and studied. Besides routine hematoxylin and 
eosin (H & E) stains, eight of ten cases were studied im-
munocytochemically for Factor VIII-related antigen to 
confirm the diagnosis. In each of these cases, cytokeratin 
and alpha-fetoprotein immunocytochemistry was nega-
tive. Those patients in whom recurrent disease developed 
had all of their pathologic material reviewed to ensure 
that the recurrences were identical to the original tumor. 
Statistical Analysis 
The collected data were incorporated into the existing 
liver transplant database of the Department of Surgery at 
the University of Pittsburgh. Data analysis was performed 
using the Life Table and Survival Function Programs of 
the BMDP statistical software package (Statistical Soft-
ware, Inc., Los Angeles, CA).12 
Results 
Survival and Tumor Recurrence 
The projected 5-year actuarial survival rate of the ten 
patients is 76%, with eight patients at risk after the first 
year, three after the second year, and two after the third 
year (Fig. 1). 
Table 2 reports the clinical outcome. None of the ten 
patients died of a complication related to the transplant 
procedure. Two died of recurrence of EHE at 3 and 16 
months, respectively, after transplantation. Recurrence 
in the first of these two patients was noticed 2 months 
after OLT, with tumor being found in the liver allograft 
and lungs. The postmortem examination in this case also 
showed tumor involving the brain, spleen, pancreas, kid-
neys, and pericardium. The second patient had a recur-
rence in the hepatic allograft 12 months after surgery. An 
autopsy also documented recurrent tumor in the lungs. 
Survival 
Chemotherapy Recurrence Metastases location status 
No No II yr, alive 
No No 4 yr, alive 
Yes 12 mo after OLT Liver, lungs 16 mo, dead 
Yes 18 mo after OLT Mediastinum, 2 yr, alive 
right lung 
No No 16 mo, alive 
Yes No 16 mo, alive 
Yes No 15 mo, alive 
No No 9 mo, alive 
No No 1 mo, alive 
No 2 mo Lungs, liver, spleen, 3 mo, dead 
pancreas, kidney, 
pericardium, brain 
Six patients are alive at 1 month (Patient 9), 9 months 
(Patient 8), 16 months (Patients 5 and 6), 4 years (Patient 
2), and 11 years (Patient 1), respectively, after transplan-
tation without any evidence of recurrence. Our first case 
might represent a case of tumor regression after surgery 
because this patient had intra-abdominal, pleural, and 
pulmonary metastases at the time ofOLT (Table 2). This 
patient, who did not receive adjuvant therapy, is alive and 
free of malignant disease 11 years after OLT. 
Two patients are alive despite the presence of recurrent 
or residual tumor. The first patient (Patient 4) underwent 
transplantation 2 years ago and recurrence was first de-
tected in the mediastinum 18 months after transplanta-
tion. In June 1987, he underwent surgery for resection of 
this metastatic mass, during which several additional me-
tastases in the right lung were detected. The second patient 
(Patient 7), who was transplanted 15 months ago, had a 
rib metastasis that was recognized before OLT (Table 2). 
" PATIENT SURVIVAL 
100 1 
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FIG. I. Five-year actuarial survival rate of ten patients with hepatic 
EHE who had OL T. 
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FIG. 2. Cross-section of liver showing multiple white nodules, some 
of which are seen in continuity with the capsule. 
Pathologic Findings 
The liver resection specimens weighed between 1400 
and 6670 g. The capsular surface in all hepatectomy spec-
imens was smooth except for the presence of some white 
tumor depressions ranging from 0.5 to 2.5 cm in diameter. 
Cross-sections of the resected liver showed multiple non-
encapsulated white nodules throughout both lobes ranging 
from I to 5 cm in greatest diameter. Some of these nodules 
were seen in continuity with the hepatic capsule. No pref-
erential localization within the hepatic parenchyma was 
evident (Fig. 2). The intervening nonmalignant hepatic 
parenchyma was normal except for cholestasis. 
On low-power examination, the tumor nodules ap-
peared to have a variable cellularity with ill-defined mar-
gins. At the gross anatomic periphery of the tumor, infil-
tration of adjacent hepatic sinusoids (Fig. 3) was evident, 
whereas the central areas showed both necrosis and scle-
rosis. Tumor invasion into the central and portal veins 
was observed with varying degrees of occlusion of their 
lumens being a common finding (Fig. 3 Inset). 
The tumor cells were surrounded by cleft-like spaces 
(Fig. 4) and formed cellular tufts (Fig. 4 Inset) reminiscent 
of "glomeruloid bodies," some of which contained per-
colating erythrocytes. In the more cellular areas, tumor 
cells were arranged in solid cords and nests and had an 
abundant eosinophilic cytoplasm mimicking "epithelioid 
cel'ls." In other less ceHular areas having a sclerotic matrix, 
single neoplastic cells had irregular cytoplasmic processes. 
Some of these cells had intracytoplasmic vacuoles that 
were mucicarmine negative (Fig. 5 and Fig. 5 Inset) and 
appeared to contain erythrocytes. Eight of ten patients in 
this series were immunocytochemically positive for Factor 
VIII-related antigen.s In each of these cases, only some 
cells were positive for Factor VIII-related antigen. 
Discussion 
Hepatic malignancy is perhaps the only diagnostic in-
dication for OL T still surrounded by controversy. The 
controversy exists because hepatocellular carcinomas and 
bile ductular cancers are associated with a high recurrence 
rate after OL T.13 Little information is available about the 
prognosis for other tumors, and essentially nothing relative 
to EHE treated with hepatic transplantation exists in the 
literature.3.lo 
The initial clinical presentation of EHE is rather non-
specific. The true incidence of this tumor is not yet known, 
FIG. 3. Low-power appearance of a tumor 
nodule showing extension of the tumor (pale 
areas) into the liver parenchyma (dark area). 
The tumor is more cellular at the periphery (H 
& E, X35). Inset: Typically, the central veins 
are densely sclerotic. However, on closer in-
spection, atypical tumor cells can be seen in the 
lumen and along the wall of the vein (H & E, 
X 125). 
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FIG. 4. Clusters of tumor cells projecting into 
clefl-like spaces within fibrocellular background 
stroma (H & E, X 125). Inset: "Glomeruloid 
bodies" formed by cytologically atypical epi-
thelioid tumor cells (H & E, X500). 
and it is highly probably that many of these tumors have 
been mistakenly diagnosed, especially before 1984? The 
pathologic diagnosis of this neoplasm often requires a 
wedge biopsy of the tumor as the architectural features 
of the tumor seen in larger biopsies, such as an intravas-
cular or intrasinusoidal growth pattern, should alert the 
pathologist to the diagnosis. Given the variable cellularity 
within any given tumor nodule, a single area of sampling 
as obtained by "tru cut" liver biopsy may not be 
FIG. S. Single tumor cells with intracyto-
plasmic vacuoles, signet ring type. in a dense 
hyalinized stroma (H & E, XSOO). Inset: H igh-
power appearance of a tumor cell containing 
an intracytoplasmic lumen within which an 
erythrocyte is seen (H & E, X I2S0). 
diagnositc lO as only a more fibrous area may be examined 
and incorrectly diagnosed as being a benign condition 
such as perivenular fibrosis rather than a malignant vas-
cular tumor. Furthermore, experience with fine-needle 
aspiration for cytologic examination of this tumor is lim-
ited. Relying on only the cytologic appearance of this tu-
mor may result in overgrading the lesion as being a highly 
malignant angiosarcoma rather than a slow growing more 
benign, albeit malignant, lesion. 
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Three patients in the current series had an incorrect 
diagnosis before examination of the entire liver. The di-
agnoses in these cases included cholangiocarcinoma, scle-
rosing hepatoma, and a high-grade angiocarcinoma. Im-
munohistochemistry used to detect Factor VIII-related 
antigen is a prerequisite for the confirmation ofEHE and 
was diagnostic in each case so studied in this series. I - 5 
Specifically, this technique allows us to reject incorrect 
initial diagnoses of sclerosing hepatic carcinoma and 
cholangiocarcinoma. The latter is typically carcinoma 
embryonic antigen, epithelial membrane antigen, and cy-
tokeratin positive, whereas hepatocellular carcinomas are 
frequently alpha-fetoprotein positive immunocytochem-
ically. The histologic separation ofEHE from high-grade 
angiosarcoma may be difficult as was the situation in one 
of the current cases. Criteria that are useful in establishing 
the correct diagnosis of angiosarcoma include the variable 
growth pattern along hepatic plates, the presence of an 
interanastomizing pattern on reticular stains, anaplastic 
cytologic features, and the presence of mitotic figures. This 
separation is important given the more aggressive course 
of angiosarcoma. It is apparent from the current series 
that EHE has a spectrum of biologic behaviors but, in 
general, has a more benign biologic behavior than angio-
sarcoma does. The conventional histopathologic variables 
useful for grading malignancy, such as necrosis, cytologic 
pleomorphism, and mitotic figures, are not evident 
in EHE. 
A direct comparison between the report of Ishak et al. 
of 32 patients with EHE and the current series is not pos-
sible. However, it is interesting to notice that only nine 
of32 (28%) of the Ishak et al. patients survived more than 
5 years. The actuarial survival rate of the EHE patients 
treated with OLT in the current series is satisfactory and 
compares favorably with that seen for OLT recipients who 
received transplants for nonmalignant disease. 14 
It remains difficult to propose a single standard thera-
peutic approach for these tumors because they occur un-
usually and their natural history is very unpredictable. 
Long-term survival without any specific therapy has been 
reported. 3 The histologic features of EHE do not appear 
to predict tumor behavior. I Thus, it is not possible to use 
the histologic characteristics of a given tumor as a guide 
for therapeutic decisions. As a result, there are different 
opinions regarding the therapeutic recommendations for 
EHE that vary from only observation in asymptomatic 
cases,15 to the excision oflocalized lesions I and OL T as 
in this series. 
We believe that surgical resection is the best course of 
action. If due to its multifocal location the tumor cannot 
be removed by a subtotal resection, it seems reasonable 
to consider liver transplantation based on the experience 
reported herein. This therapeutic approach can be used 
even in the presence of a localized number of small me-
tastases because the natural course of the disease is so 
favorable. This was demonstrated by one of the patients 
in this series who, despite metastatic disease at the time 
of OLT, is currently alive 11 years later and has an ap-
parent spontaneous resolution of the metastases. 
We do not have sufficient data to define a role for che-
motherapy, radiotherapy, or both in the treatment of this 
tumor. Thus, prospective studies should be performed. 
In conclusion, OLT appears to be a reasonable thera-
peutic approach for hepatic EHE when the tumor is not 
resectable except as a total hepatectomy. 
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